We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, we will look at where ...

Italian startup Aptadir has launched with $1.6M to develop drugs targeting DNA hypermethylation for cancer and genetic ...

In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D ...

Many cellular functions in the human body are controlled by biological droplets called liquid-liquid phase separation (LLPS) ...

HCV testing was conducted in fewer than half of perinatally exposed children, with the lowest odds observed in Black, Asian/Pacific Islander, and Hispanic/Latinx populations.

Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...

Two biotechs are teaming up to deliver cholesterol-busting mRNA to clogged arteries. | Two biotechs are teaming up to deliver ...

Supports Bentrio growth strategy together with strategic contract manufacturer and expanding network of international distributors ...

Sarepta dominates the Duchenne muscular dystrophy (DMD) market. Read why recent insider buying of Sarepta stock may signal ...

The following is a summary of “Transient stabilization of human cardiovascular progenitor cells from human pluripotent stem cells in vitro reflects stage-specific heart development in vivo,” published ...

The free COVID-19 tests promised by the U.S. government are now available. "U.S. households will be eligible to order four ...

Researchers at the University of Geneva developed CAR-T cells targeting the glioblastoma marker PTPRZ1, showing efficacy ...